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The Interplay of Dental Pulp Stem Cells
and Endothelial Cells in an Injectable Peptide Hydrogel
on Angiogenesis and Pulp Regeneration In Vivo
Waruna Lakmal Dissanayaka, BDS, PhD,1 Kenneth M. Hargreaves, DDS, PhD,2 Lijian Jin, DDS, PhD,3
Lakshman P. Samaranayake, DSc, DDS, FRCPath,4 and Chengfei Zhang, DDS, PhD1
Securing an adequate blood supply for the survival of cell transplants is critical for a successful outcome in tissue
engineering. Interactions between endothelial and progenitor/stem cells are important for vascularization of re-
generating tissue. Recently, self-assembling peptide nanofibers were described as a promising environment for pulp
regeneration due to their synthetic nature and controlled physicochemical properties. In this study, the peptide
hydrogel PuraMatrix was used as a scaffold system to investigate the role of dental pulp stem cells (DPSCs)
in triggering angiogenesis and the potential for regenerating vascularized pulp in vivo. Human umbilical vein
endothelial cells (HUVECs), DPSCs, or cocultures of both cell types were encapsulated in three-dimensional
PuraMatrix. The peptide nanofiber microenvironment supported cell survival, cell migration, and capillary network
formation in the absence of exogenous growth factors. DPSCs increased early vascular network formation by
facilitating the migration of HUVECs and by increasing vascular endothelial growth factor (VEGF) expression.
Both the DPSC-monoculture and coculture groups exhibited vascularized pulp-like tissue with patches of osteo-
dentin after transplantation in mice. The cocultured groups exhibited more extracellular matrix, vascularization, and
mineralization than the DPSC-monocultures in vivo. The DPSCs play a critical role in initial angiogenesis, whereas
coordinated efforts by the HUVECs and DPSCs are required to achieve a balance between extracellular matrix
deposition and mineralization. The findings of this study also highlighted the importance of a microenvironment
that supports cell–cell interactions and cell migration, which contribute to successful dental pulp regeneration.
Introduction
Rapid vascularization of a bioengineered tissue/scaffold transplant following implantation in vivo is
critical for a successful outcome in tissue engineering. The
human tooth has a unique architecture with an internal pulp
space encased in a thick dentin wall, and the dental pulp
only consists of a microcirculatory system originating from
a very small opening at the apex of the root. This anatomical
configuration hinders the development of an adequate vas-
cular supply during pulp regeneration. Consequently, on
in vivo transplantation of teeth the tissue constructs must
depend solely on the oxygen supply that is delivered via
diffusion from the nearest capillary.1 Oxygen diffusion is
effective up to a distance of*200mm from a blood vessel2
and the majority of cells undergo hypoxia when located
further from a blood vessel.3 The survival of a larger im-
planted tissue construct requires the formation of an intrinsic
capillary network to exchange gases, nutrients, and wastes
between the cells and the vascular system. Although host
blood vessels invade the implanted tissue construct, partially
in response to the angiogenic factors secreted by hypoxic
cells, this process occurs very slowly, with vessels growing
only a few tenths of a micrometer per day.1 Therefore, the
development of methods to promote rapid vascularization of
a tissue construct following in vivo implantation is critical
for improved functional integration.
To develop novel strategies to promote vascularization of
engineered pulp constructs, it is necessary to understand the
interactions between the major cell types within the pulp.
Dental pulp stem cells (DPSCs), which have been identified
as a promising progenitor cell population for pulp repair and
regeneration, are known to occupy a perivascular niche.
Therefore, DPSCs and endothelial cells (ECs) are physically
poised to regulate their respective functions. We recently
demonstrated that a coculture of human umbilical vein
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endothelial cells (HUVECs) and DPSCs synergized osteo/
odontogenic and angiogenic differentiation in monolayer
cultures.4 However, less information is available regarding
the interactions between DPSCs and ECs/HUVECs in a
three-dimensional (3D) microenvironment, which may sig-
nificantly influence their behavior and functionality.
Prevascularization of the cell/scaffold construct by ECs is
considered a promising approach to achieve rapid anasto-
mosis between the bioengineered cellular/tissue construct
and the host vasculature.1,5 However, this is a challenging
task because ECs are sensitive to their microenvironment
and tend to undergo apoptosis after encapsulation in most
scaffold materials.6 External growth factors often have to be
supplied to promote in vitro angiogenesis. Therefore, a 3D
culture system that mimics the natural cell milieu while
uncoupling the scaffold-triggered signaling from cell–cell
interactions may provide vital insights into the role of EC-
DPSC interactions during angiogenesis.
The exceptional anatomy of root canals also poses difficulties
for using rigid scaffold systems in pulp regeneration because it
is difficult to insert them into the narrow, tapering root canals.
Therefore, being able to inject a scaffold system into root canals
would be an added advantage when selecting a scaffold for
dental pulp regeneration. Using a scaffold with specific fibrous
structures that ideally mimic the extracellular matrix of the
target tissue is critical in a scaffold-based regenerative ap-
proach.7 Additionally, in terms of dental pulp regeneration, the
scaffold should be capable of promoting odontoblastic differ-
entiation of stem/progenitor cells. Therefore, an ideal scaffold
for dental pulp regeneration should be injectable and EC
friendly and should facilitate odontoblastic differentiation.
Emerging data suggest that the self-assembling peptide hy-
drogel PuraMatrix may fulfill several of these requirements.
PuraMatrix is a repeating polymer of the amino acid sequence
R-A-D-A and is formulated as an injectable scaffold that as-
sembles into nanofibers when exposed to physiologic concen-
trations of salts. This scaffold has been used in several studies
and has yielded promising results for cardiac,8–11 neural,12,13
hepatic,14 and bone15 tissue regeneration. Furthermore, Pura-
Matrix has been shown to be capable ofmaintaining the viability
and odontogenic differentiation capacity of DPSCs.16 A recent
study found that stem cells from exfoliated deciduous teeth that
were encapsulated in PuraMatrix and injected into full-length
root canals gave rise to functional odontoblasts and pulp-like
tissue after transplantation into immunodeficient mice.17
This study aimed to elucidate the DPSC-HUVEC inter-
actions during angiogenesis and odonto/osteogenic differ-
entiation in a 3D peptide-hydrogel system. We investigated
cell viability, vascular network formation, and the differ-
entiation capacity of mono- or cocultured DPSCs and
HUVECs seeded in PuraMatrix and examined the potential
of prevascularized PuraMatrix-encapsulating DPSCs to re-
generate dental pulp-like tissues in vivo.
Materials and Methods
Isolation, culturing, and characterization of cells
After obtaining informed consent, DPSCs were isolated
from freshly extracted sound third molars from human
subjects aged 18 to 25 years, as described previously.18
Briefly, the surfaces of the freshly extracted teeth were
cleaned and cut at the cementoenamel junction using a
sterile fissure bur to reveal the pulp chamber. After gently
separating the pulp tissue from the crown and root, it was
digested in a solution containing 3mg/mL collagenase type I
(GIBCO-Invitrogen, Carlsbad, CA) and 4mg/mL dispase
(GIBCO-Invitrogen) for 1 h at 37C. Then, the cells were
passed through a 70-mm strainer (BD Biosciences, Franklin
Lakes, NJ) to obtain single-cell suspensions. These cells
were seeded in 75-cm2 culture flasks containing a-minimum
essential medium (a-MEM) supplemented with 15% fetal
bovine serum, L-ascorbic acid-2-phosphate, 100 U/mL
penicillin-G, 100mg/mL streptomycin, and 0.25mg/mL
fungizone (Gemini Bio-Products, Woodland, CA) and cul-
tured under 5% CO2 at 37C. DPSCs isolated from three
human donors were characterized and used individually in
triplicate experiments. HUVECs that were obtained com-
mercially (ScienCell Research Laboratories, San Diego,
CA) were cultured in endothelial cell medium (ECM; Scien-
Cell Research Laboratories) at 37C with 5% CO2. Cells from
passages 3 to 6 of each cell type were used in all experiments
according to the parameters described below.
Characterization of DPSCs
Before using the DPSCs for experiments, the ‘‘stemness’’
of the freshly isolated cells was assessed by flow cytometric
analysis of the expression of mesenchymal stem cell markers
CD73, CD90, CD105, STRO-1, and hematopoietic marker
CD45. In addition, the multilineage differentiation capac-
ity of the DPSCs was confirmed using osteo-/odontogenic,
adipogenic, and neurogenic induction media as described
previously.4,19,20
Cell encapsulation within PuraMatrix
Monocultures and cocultures of different ratios (3:1, 1:1, or
1:3) of DPSCs and HUVECs were encapsulated in different
concentrations (0.5%, 0.25%, or 0.15%) of PuraMatrix (BD-
Biosciences, Bedford, MA). Briefly, the viscosity of the BD
PuraMatrix stock solution (1% w/v) was reduced by vortex-
ing, and air bubbles were removed by centrifuging. The
necessary volume of the desired concentration of PuraMatrix
was prepared by diluting the stock with sterile 20% sucrose to
generate a 2· concentration of PuraMatrix in 10% sucrose
(except for 0.5% PuraMatrix). The cells were trypsinized and
centrifuged at a concentration of 1· 106 cells/mL. The me-
dium was removed from the cell pellet, and the cells were
resuspended at the desired density in sterile 10% sucrose. The
cells were centrifuged again to remove any remaining salts
and resuspended in 10% sucrose at twice the final desired
cell concentration. Equal volumes of 2· PuraMatrix and a
2· cell/sucrose mixture were mixed and then carefully added
to the center of the well without introducing air bubbles. The
ratios of different solutions mixed to prepare 2mL working
concentrations of cell/PuraMatrix constructs were summa-
rized in Table 1. Gelation of the PuraMatrix was initiated by
gently running culture media down the side of the well on top
of the hydrogel. The medium was gently changed twice over
the next hour to equilibrate the pH of the hydrogel.
Transwell assay
The Transwell culture model was used to indirectly co-
culture DPSCs and HUVECs encapsulated in PuraMatrix. In
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this model, the DPSCs were maintained as a monolayer in the
culture wells, and HUVECs encapsulated in PuraMatrix were
layered onto the culture insert of a 24-well Transwell plate.
The DPSCs were cultured overnight before the HUVEC/
PuraMatrix was placed on the inserts. Alternatively, HUVEC/
PuraMatrix was cultured using the normal medium or medium
supplemented with recombinant human vascular endothelial
growth factor (VEGF) 165 (50 ng/mL; R&D Systems, Inc.,
Minneapolis, MN) on cell culture inserts with no DPSC
monolayer in the lower compartment.
Live/Dead viability assay
Cell viability in the cell/scaffold constructs was assessed
at 24 h, 4 days, and 2 weeks after encapsulation using a
Live/Dead/Viability/Cytotoxicity kit (Molecular Probes,
Inc., Eugene, OR). As recommended by the manufacturer,
the cell/scaffold constructs were rinsed with PBS and then
treated with a PBS solution containing 2mM ethidium
homodimer-1 and 4mM calcein AM for 30min. The sam-
ples were then washed with PBS and observed using con-
focal microscopy. Live cells with green fluorescence were
quantified using CellProfiler, cell image analysis software.
Quantification of VEGF by ELISA
VEGF165 released by the monocultures and the cocultures
of different ratios were detected using a specific ELISA kit
(Quantikine; R&D Systems, Inc., Minneapolis, MN). Super-
natants from independent cultures of DPSCs, HUVECs, and
cocultures at 24 h, 48 h, and 4 days were collected, stored at
- 80C, and then submitted to the immunoenzymatic detec-
tion, according to the protocol described by the manufacturer.
The results were expressed as pg VEGF/mg protein.
Transfection of cells with green fluorescent protein
and red fluorescent protein constructs
DPSCs and HUVECs were transfected for the expression
of green fluorescent protein (GFP) and red fluorescent pro-
tein (RFP), respectively, using premade GFP and RFP len-
tiviral particles (GenTarget, Inc., San Diego, CA). The
transfection procedure was carried out as described by the
manufacturer and stably expressing cell lines were selected
using G418 antibiotic.
In vitro prevascularization of PuraMatrix
Monocultured or cocultured DPSCs and HUVECs that were
expressing GFP and RFP, respectively, were encapsulated in
PuraMatrix as described above. The cellular morphologies and
3D organization of the cells within the scaffold were moni-
tored using confocal microscopy for 2 weeks. In addition,
DPSC:HUVEC co-encapsulated PuraMatrix was injected
into the root canals of root segments and observed whether
the vascular structures are formed within the root canal
environment.
Odonto/osteogenic differentiation assays
Odonto/osteogenic differentiation of cultures was in-
duced in the cocultured encapsulated cells using coculture
medium supplemented with 10 nM dexamethasone, 10mM
b-glycerophosphate, 50 mg/mL L-ascorbic acid phosphate,
and 10 nM 1,25 dihydroxyvitamin D3 for 21 days.
4,19,20 The
differentiation of DPSC-only cultures was induced using
DPSC medium supplemented with the above-mentioned
odonto/osteogenic factors.
ALP activity
The cultures were rinsed twice with ice-cold phosphate-
buffered saline, solubilized using Tris/glycine/Triton buffer
(pH 10.5, 50mM Tris, 100mM glycine, and 0.1% Triton X-
100), and sonicated on ice using two 15-s pulses. The su-
pernatants were collected and used to determine the total
protein and ALP levels. The total protein levels were de-
termined using a BCA protein assay kit (Thermo Scientific,
Pierce Biotechnology, Rockford, IL). A 100 mL aliquot of a
freshly prepared p-nitrophenyl-phosphate (PNPP) solution
was added to 200mL of the supernatant mixed with Tris/
glycine/Triton buffer and incubated for 30min at 37C. The
optical density of p-nitrophenol at 405 nm was measured
using spectrophotometry. The ALP activity was expressed
as nanomoles of PNP per milligram of protein per minute.
von Kossa staining for mineralization
The PuraMatrix/cell constructs were fixed using 4%
paraformaldehyde, dehydrated, and embedded in paraffin.
Five-micrometer sections were cut, deparaffinized, and re-
hydrated to water. The sections were incubated with 1%
silver nitrate solution placed under ultraviolet light for
20min. After rinsing with distilled water, the unreacted
silver was removed by soaking in 5% sodium thiosulfate for
5min. The sections were counterstained with nuclear fast
red dye for 5min.
Pulp regeneration in vivo in a SCID mouse model
The roots of freshly extracted human teeth were horizon-
tally sectioned into 10mm-long segments. The root canals
were cleaned and shaped using rotary instruments (ProTaper
and ProFile, Dentsply Tulsa Dental). The root canals were
smoothed using the following sequences of files: SX, S1, S2,
F1, F2, and F3. These root fragments were soaked at room
temperature in 17% ethylenediamine tetraacetic acid (EDTA)
for 10min and then in 19% citric acid for 1min to remove the
smear layer and subsequently treated with betadine for 30min
and 5.25% NaOCl for 10–15min to remove the organic
component, the debris originating from pulp tissue and mi-
croorganisms. The fragments were then rinsed with sterile
PBS, soaked in PBS, and then incubated at 37C for 3–7 days
to remove the residual disinfection agents and ensure that
there was no microbial contamination.
Table 1. Preparation of Different
Concentrations of PuraMatrix
Final
PuraMatrix
concentration
(%)
1%
PuraMatrix
(stock) (lL)
20%
Sucrose
(lL)
DI
water
(lL)
2 · cell
suspension
in 10%
sucrose (lL)
0.5 1000 — — 1000
0.25 500 500 — 1000
0.15 300 500 200 1000
DI, deionized.
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The following five experimental groups were created: (1)
empty root segments; (2) root segments with PuraMatrix
alone; (3) root segments with PuraMatrix +DPSCs (4) root
segments with PuraMatrix+ 3:1 DPSCs:HUVECs; and (5)
root segments with PuraMatrix+ 1:1 DPSCs:HUVECs. Eight
root segments from each group were placed in a total of 20
mice. The coronal end of each root segments was sealed with
MTA so that only the apical end was open to the external
environment, which was 500–1000mm in diameter. After
suspending the cells in PuraMatrix, the mixtures were in-
jected into the root segments and incubated overnight in the
normal culture medium. Root segments from the different
groups were bilaterally implanted in the subcutaneous space
of the dorsum of 5- to 7-week-old female severe combined
immunodeficient mice (CB.17 SCID) (Fig. 1). After 4 weeks,
the implants were retrieved, fixed in 4% formaldehyde for
24 h, demineralized with EDTA until the dentin offered no
resistance to being cut with a blade (4 weeks), and then
processed for histology and immunohistochemistry.
Histology and immunohistochemistry
Hematoxylin and eosin staining was performed to ex-
amine the morphology and structure of the regenerated pulp-
like tissues. Immunohistochemistry using human-specific
mitochondrial [Abcam (Hong Kong) Ltd. HKSP, N.T. Hong
Kong] and human-specific CD31 (Santa Cruz Biotechnol-
ogy, Inc., Dallas, TX) antibodies was conducted to confirm
the contribution of the transplanted DPSCs and HUVECs,
respectively, to the regenerated tissues. Human specific anti-
nestin antibody [Abcam (Hong Kong) Ltd. HKSP] and anti-
dentin sialoprotein (DSP) antibody (Santa Cruz Biotechnology,
Inc.) was used to detect the odontoblastic lineage of the cells in
newly formed pulp-like tissues.
Quantification of blood vessels
To quantify the blood vessels, three sections per root-slice
that were stained with a human-specific anti-CD31 antibody
and counterstained with hematoxylin were analyzed. Mi-
croscopic images were taken at 20· magnification in three
random areas per section. EC-lined lumens were counted
as total vascular lumens. To determine the density of the
human microvessels (mean number of capillaries per square
millimeter), the number of structures with lumens sur-
rounded by human-CD31 + cells was counted manually. EC-
lined vessels containing intraluminal red blood cells were
considered perfused lumens, whereas lumens without red
blood cells were considered nonperfused lumens. The values
are given as the mean value – standard deviation.
Statistical analysis
The ALP concentration, relative expression levels of
the genes, and number of vessels were expressed as a
mean – standard deviation and were statistically analyzed
using nonparametric statistical test Kruskal–Wallis one-
way analysis of variance. p< 0.05 was considered statisti-
cally significant.
Results
In vitro characterization of DPSCs
Freshly isolated DPSCs showed odonto/osteogenic, neu-
rogenic, and adipogenic differentiation after being induced
by relevant induction media for a period of 3 weeks (Fig.
2A–C). The results of the flow cytometric analysis showed
positivity for STRO-1, CD73, CD105, and CD90, which
confirmed the mesenchymal stem cell lineage of the DPSCs
(Fig. 2D). Further, the DPSCs were negative for hemato-
poietic marker CD45 (Fig. 2D).
Cell viability, survival, and proliferation within PuraMatrix
The Live/Dead assay revealed that 0.15% was the optimal
PuraMatrix concentration for HUVECs compared to 0.5%
and 0.25% PuraMatrix, in which the HUVECs did not survive
after encapsulation. In contrast, the DPSCs survived in Pura
Matrix at all three concentrations. Thus, PuraMatrix was used
at a concentration of 0.15% in all subsequent experiments
described in this study.
When DPSCs and HUVECs were seeded as monocultures
in 0.15% PuraMatrix, the DPSCs survived and grew faster
than did the HUVECs (Fig. 3). The HUVECs did not survive
longer than 2 weeks in monocultures (Fig. 3C, F, I). Cell
survival was significantly higher (Fig. 3J) in cocultures than
in either DPSC or HUVEC monocultures (Fig. 3B, E, F).
Furthermore, vessel-like structures formed near the DPSCs in
the cocultures (Fig. 3E). These findings suggested that co-
culturing DPSCs and HUVECs in PuraMatrix promoted
HUVEC survival and the secretion of angiogenic factors that
induced vessel-like structure formation.
DPSCs promote endothelial tube formation
via soluble factors
Unlike the cells in the HUVEC/PuraMatrix monocultures
(i.e., without a DPSC monolayer in the lower compartment)
(Fig. 4A–C), the cells in the HUVEC/PuraMatrix wells
cultured for 48 h over a DPSC monolayer had round to
spindle-shaped morphologies and were organized in a tubal
network (Fig. 4G–I). Similar morphological changes were
observed in the cells when HUVEC/PuraMatrix wells were
FIG. 1. SCID mouse model for
the subcutaneous transplantation
of human tooth root fragments
loaded with cell/PuraMatrix
constructs. The canal space of the
human tooth root fragments (10-
to 11-mm long) was enlarged to
*0.5–1.5mm in diameter. One
end of the canal opening was
sealed using MTA cement.
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cultured in medium supplemented with VEGF (at 50 ng/mL)
(Fig. 4D–F). In contrast, the cells in the HUVEC/PuraMatrix
wells that were cultured in normal medium did not arrange
into a tubal network (Fig. 4A–C). These results suggested
that DPSCs secrete pro-angiogenic growth factors that in-
hibit EC apoptosis and promote tube formation.
DPSCs secrete VEGF
Quantitative determination of VEGF165 indicated that the
VEGF levels in the medium were largely determined by the
DPSCs. Significantly higher VEGF165 contents were de-
tected in the DPSC monocultures (Fig. 4J) than in the co-
cultures at all the time points. The results also indicated that
the decrease in the VEGF level in cocultures was propor-
tional to the number of HUVECs that were incorporated.
This finding suggests that in cocultures, the VEGF that is
secreted by the DPSCs might be immediately utilized by the
HUVECs to activate signaling for migration and vascular
structure formation. At day 4, a significantly higher level of
VEGF was detected in the cocultures (DPSC:HUVEC 3:1
and 1:1) compared to days 1 and 2, which correlated with
the presence of a relatively well-developed vascular network
by day 4.
Prevascularization of DPSC/PuraMatrix
constructs by HUVECs
Immediately after seeding was completed, both the HU-
VECs and DPSCs attached and uniformly spread across the
peptide hydrogel (Fig. 3A–C). Coordinated migration of
DPSCs and HUVECs was observed after 48 h (Fig. 5A–C),
with DPSCs being near the nascent HUVEC networks and a
distinct lack of these cells outside the networks. By day 3, an
extensive vessel-like network was observed throughout the
cocultured PuraMatrix scaffold (Fig. 5D–F), whereas the
HUVEC monocultures failed to form any vessel-like struc-
tures (Fig. 5G–I). The vessel structures that formed within the
cocultures were three-dimensionally organized and signifi-
cantly larger (Fig. 5D–F) than the tubular structures observed
in the HUVEC monocultures in the presence of DPSC-
conditioned medium (Fig. 4G–I) or VEGF (Fig. 4D–F). A low
density of vessel-like structures was observed when the EC
number was higher (not shown). A 3:1 ratio of DPSC:HUVEC
was identified as optimal for vessel structure formation
in vitro. The vessel-like network continued to remodel and
remained in a stable condition for 2 weeks in vitro (Fig. 5J–O).
When the DPSCs and HUVECs were co-encapsulated
in PuraMatrix and injected into root canals of root
FIG. 2. Characterization of DPSCs isolated from freshly extracted human third molars. Osteo/odontogenic differentiation–
mineralized nodule formation as shown by Alizarin Red staining after 3 weeks of induction (A). Neurogenic differentiation—
bIII-tubulin expression with long cellular processes while maintaining the spindle-shaped fibroblastic cell bodies after 3
weeks of induction as shown by immunofluorescence imaging (B). The green fluorescence shows the positivity for bIII-
tubulin. Adipogenic differentiation—lipid droplet formation as shown by Oil Red O staining after 3 weeks of induction (C).
Expression of mesenchymal stem cell markers STRO-1, CD90, CD105, CD73, and hematopoietic marker CD45 as analyzed
by flow cytometry (D). DPSCs, dental pulp stem cells.
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FIG. 3. Live/Dead assays were performed on the mono- and cocultures at different time points after the cells were
encapsulated in 0.15% PuraMatrix, with cell number quantification by Cell Profiler, cell image analysis software ( J). The
DPSC:HUVEC 3:1 coculture (B, E, H) exhibited a significantly higher rate ( J) of cell survival than DPSC (A, D, G) and
HUVEC monocultures (C, F, I). Vessel-like structures were observed in the cocultures (White arrows in E). HUVEC,
human umbilical vein endothelial cell.
FIG. 4. The DPSCs supported vascular morphogenesis by the HUVECs. HUVECs/PuraMatrix cultured in normal medium
did not develop any tubular, vessel-like structures (A–C). HUVECs/PuraMatrix cultured in medium supplemented with
VEGF 165 (50 ng/mL) initiated the formation of vessel-like structures (D–F). HUVECs/PuraMatrix cultured on a cell
culture insert with a DPSC monolayer in the lower compartment developed tubular vessel-like networks (G–I). A-I: Live/
Dead staining at 48 h. (J) Quantitative determination of the VEGF165 content of the supernatants of mono- and cocultures of
DPSCs and HUVECs using ELISA, expressed as pg VEGF/mg protein at 24 h, 48 h, and 4 days. The DPSC monocultures
had significantly higher VEGF levels in their supernatants than the cocultures and HUVEC monocultures at all three time
points. The decrease in the VEGF level in cocultures was proportional to the number of HUVECs that were incorporated
into the cocultures. The VEGF levels began to increase in the supernatants of the cocultures after 48 h of cultivation. VEGF,
vascular endothelial growth factor.
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segments, vessel structure formation was observed after
24 h of initial encapsulation (Fig. 5P–R). This finding
suggested that the prevascularized PuraMatrix/cell con-
structs can be transplanted in vivo after incubation for
24 h in vitro.
ALP activity
To investigate whether PuraMatrix provides a permissible
environment for the odonto/osteogenic differentiation of
DPSCs, we quantified the ALP activity in 3D mono- and
FIG. 5. Vessel-like structure for-
mation by HUVECs that were co-
cultured as PuraMatrix constructs
(Green: green fluorescent protein-
expressing cells, Red: red fluorescent
protein-expressing cells). (A–C) Co-
ordinated cell migration was ob-
served in the cocultures 48 h after
seeding. (D–F) Vessel-like structure
formation by HUVECs was observed
in the cocultures 3 days after seed-
ing, with DPSCs surrounding the
nascent HUVEC networks. (G–I)
HUVEC monocultures did not ex-
hibit cell migration or vessel struc-
ture formation. ( J–O) Vessel-like
networks continued to be remodeled
and to stabilize for 2 weeks. (P–R)
Vascular structure formation was
observed after 24 h when cocultured
PuraMatrix was injected into root
canals of root segments.
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cocultures of DPSCs and HUVECs. At 7 days in coculture
with HUVECs, the DPSCs displayed a significantly higher
level of ALP activity than the DPSCs in monocultures
( p < 0.05) (Fig. 6E). This result confirmed that coculturing
DPSCs can enhance their odonto/osteogenic differentiation
in 3D and that PuraMatrix is a suitable scaffold for dental
pulp regeneration.
von Kossa staining to assess mineralization
Mineralization in the cultures that were treated with
odonto/osteogenic differentiation inducers was examined
using von Kossa staining, which revealed a larger amount of
mineralization in the cocultures compared with the mono-
cultures (Fig. 6A–D).
Pulp regeneration in vivo
Analysis of pulp-like tissue. Empty root segments and
root segments with PuraMatrix alone (i.e., no cells) did not
contain any pulp-like tissue (Fig. 7A, B) at 4 weeks after
transplantation. Interestingly, in these two groups, not even
the ingrowth of mouse subcutaneous fat tissue was evident
within the root canals. This result confirmed that PuraMatrix
does not possess an intrinsic capability to attract endogenous
cells to populate the scaffold structure.
In contrast, pulp-like tissue regeneration occurred in all three
of the cell-transplantation groups (DPSC-alone, DPSC:
HUVEC 1:1, and DPSC:HUVEC 1:3) within the root canal
(Fig. 7C–H). In vitro suspended PuraMatrix/cell constructs
of all three groups were successfully integrated into the host
tissues and vasculature. Importantly, PuraMatrix/cell con-
structs that were located near the coronal end of the root,
where the opening was sealed, could not survive (Fig. 7C–
E). Therefore, pulp-like tissue regenerated only up to the
middle (5mm) to lower third (3.3mm) of the root canals. In
the root fragments in which the apical root opening was
larger than average, ingrowing host tissue was observed to
push the PuraMatrix/cell transplant toward the coronal end
(Fig. 7E, H).
Osteodentin/predentin formation was observed adjacent
to the existing dentin surface in the cocultured groups (Fig.
8A, B). An odontoblast-like cell layer was observed adja-
cent to the existing dentin (Fig. 8C) in the regenerated pulp-
like tissue. Positive immunohistochemical staining of these
cells to odontoblast markers, DSP (Fig. 8E) and nestin (Fig.
8F) suggested their odontoblastic lineage. Increased vascu-
lature was observed at the border between the transplanted
tissue and host tissue (Fig. 8D).
The DPSC:HUVEC cocultured groups exhibited en-
hanced extracellular matrix formation with high amounts of
collagen deposition compared with the DPSC-alone group,
which displayed loosely arranged tissue with less cellularity
and matrix material (Fig. 9A, C, H).
Positive staining with antibodies against human mito-
chondria confirmed that the transplanted cells contributed
to the regenerated pulp-like tissue in all three groups (Fig.
9B, D, F).
Analysis of neovascularization. Enhanced vasculature
was observed in the cocultured groups (DPSC:HUVEC 3:1
and 1:1) compared to the DPSC-only group (Fig. 9B, D, F).
Quantification of the number of vascular lumens revealed
significantly more ( p< 0.05) vessels in the cocultured groups
compared with the DPSC-alone group (Fig. 10D).
Immunohistochemical staining of human CD31 demon-
strated HUVEC-lined vascular lumens in the cocultured
groups, and as expected, none of those structures were
detected in the DPSC-only group (Fig. 10A–C). The ma-
jority of the perfused vessels found in the cocultured groups
were CD31 + , suggesting that the HUVEC prevascular
structures that had formed in vitro had integrated into the
host vasculature (Fig. 10A, C). However, most of the vas-
cular lumens that were located toward the periphery of the
transplant and distant from the host tissues were not vas-
cularized (Fig. 10B).
Discussion
Scaffold materials play an important role in tissue engi-
neering because they provide structural support for progenitor/
stem cells and integrate cell–cell and cell–extracellular matrix
cross-talk.7 Although pulp regeneration studies have described
several types of scaffolds, most of this work has focused on
the odonto/osteogenic differentiation capacity of progenitor/
stem cells.21,22 An increasing number of studies have sug-
gested that odonto/osteogenic and angiogenic processes are
interdependent through the close interaction of stem/progenitor
cells and ECs or their progenitor cells.23,24 We describe here,
for the first time, the feasibility of using a peptide hydrogel
scaffold to regulate the functions of DPSCs and HUVECs in
angiogenesis and odontogenic differentiation in mono- and
coculture systems. In this model, the interactions between
DPSCs and HUVECs occurred via direct cell–cell contacts
and paracrine signaling. In addition, the extracellular matrix
produced by the DPSCs may have also promoted the sta-
bilization and remodeling of capillary-like structures formed
by the HUVECs.
The DPSC isolation protocol used in this study was
identical to that previously reported for isolation of DPSCs
from human teeth.4,18,19 Whole populations of low passage
cells were used for all experiments rather than sorted sub-
populations as these are the cells that would likely be used
clinically. Therefore, the term DPSCs used in this study and
in many other recently published studies does not refer to
pure stem cells.4,18–20 This population of cells contains
immature stem/progenitor cells together with fibroblasts,
ECs, and pericytes released from the pulp tissue.18
The process of angio/vasculogenesis plays a major role in
the integration and engraftment of transplanted bioengineered
cellular/tissue constructs. Prevascularization of the engineered
tissue construct with an engineered ghost capillary network is
considered a promising approach; in this approach, the con-
struct can rapidly anastomose with the host vasculature once
transplanted in vivo. However, it is difficult to fabricate a
stable vascular network in vitro because ECs require specific
environment elements, such as a specific pH range, signaling
molecules, and growth factors, for their survival, proliferation,
migration, and vascular morphogenesis.25 The present report
described a stable HUVEC vascular network supported by
DPSCs within a peptide hydrogel scaffold, PuraMatrix, which
supported the survival, proliferation, and functionalization of
both types of cells.
The commercially available peptide hydrogel scaffold
PuraMatrix, which was used in this study, is a synthetic
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FIG. 6. Osteo/odontogenic differentiation in mono- and cocultures within PuraMatrix. (A–D)Mineralization in the mono-
and cocultures of PuraMatrix constructs at 3 weeks of induction, as shown by von Kossa staining (black: calcium deposits,
pink-red: nuclei). (A) DPSC:HUVEC 3:1 (4 · ), (B) magnified view of panel A (10 · ), (C) DPSC-alone (4 · ), (D)
magnified view of panel C (10 · ). (E) Quantitative determination of ALP in mono- and cocultures of DPSCs and HUVECs
in PuraMatrix constructs, demonstrating a significantly higher ALP level in the DPSC:HUVEC 3:1 culture on day 7
compared with that of the monocultures.
FIG. 7. Pulp regeneration in cell/Pura-
Matrix constructs in vivo 4 weeks after
transplantation. (A) Empty roots, (B)
PuraMatrix-alone in root fragments (black
arrows indicate the remnants of PuraMa-
trix), (C, F) DPSC-alone in PuraMatrix,
(D, G) DPSC:HUVEC 3:1 in PuraMatrix,
(E, H) DPSC:HUVEC 1:1 in PuraMatrix.
Vertical black arrows indicate the border
between the transplanted tissue and host
tissue.
558
FIG. 8. Pulp-like tissue within the cell/PuraMa-
trix transplantation groups. (A, B) Osteodentin
(black arrows) formation adjacent to the existing
dentin in a DPSC: HUVEC 3:1 coculture. (C)
Odontoblast-like cells aligned with the existing
dentin. (D) Increased vasculature at the border
(vertical black arrows) between the transplant and
host tissue. (E, F) Immunohistochemical staining
for human DSP and Nestin respectively. Black
arrows indicate the positively stained cells. DSP,
dentin sialoprotein.
FIG. 9. Pulp-like tissue regenerated in the mono-
and cocultured constructs in vivo (magnification:
20 · ). (A, C, E) Hematoxylin and eosin staining,
(B, D, F) immunohistochemical staining of human
mitochondria. The vertical black arrows indicate
the border between the transplant and host tissue.
Green arrows indicate the positively stained cells.
DPSC-alone in PuraMatrix resulted in loosely ar-
ranged connective tissue with comparatively less
extracellular matrix and vasculature (A, B). Co-
cultures of DPSC:HUVEC at 3:1 (C, D) and 1:1
(E, F) in PuraMatrix contained significantly more
vascular lumens. Significantly increased extracel-
lular matrix deposition was observed in the
DPSC:HUVEC 1:1 group (E, F).
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matrix comprising a repeated polymer of four amino acids
(R-A-D-A) and water. In the presence of physiologic salt
concentrations, the peptide component self-assembles into a
hydrogel that exhibits a nanofibrous structure. PuraMatrix
forms a relatively soft fibrous matrix once 1% stock so-
lution is diluted to achieve working concentrations. How-
ever, at concentrations lower than 0.15%, it becomes very
fragile and impossible to handle and inject into root canals.
Therefore, it was not possible to test concentrations lower
than 0.15%. The results of the present study demonstrated
that HUVECs remained viable only in the 0.15% peptide
hydrogel micro-environment and contributed to the de-
velopment of a capillary network when cocultured with
DPSCs. The appearance of the endothelial networks that
developed in the DPSC:HUVEC cocultures was similar to
that of the capillaries that formed in this material when
HUVECs were cultured with 50 ng/mL VEGF, as reported
previously.26,27 The rationale for using 50 ng/mL VEGF is
that it is the physiologically achievable level of VEGF
sufficient for EC survival.28,29 We fabricated the HUVEC
vascular network by coculturing HUVECs with DPSCs
without adding VEGF. This accomplishment indicated that
DPSCs can be used as a replacement for exogenous VEGF
in fabricating a HUVEC capillary network.
Interestingly, VEGF secretion by the DPSCs in the cocul-
tures appeared to be precisely orchestrated with parallel stages
of the initial angiogenic process. The angiogenic process
appears to begin with the VEGF-induced activation of ECs
and capillary sprouting.30 The levels of the VEGF that is
utilized by the ECs gradually decrease when sprouting is re-
placed with capillary stabilization. Consistent with this phe-
nomenon, the results of this study indicated that the VEGF
levels in the supernatants of DPSC-HUVEC cocultures were
lowest during the first 48h (i.e., when the VEGF that is se-
creted by the DPSCs is used by the HUVECs) and then began
to increase.
It was shown that cell migration and the corresponding
scaffold disruption promote capillary morphogenesis and
stabilization during the early stages of vasculogenesis.31 In
line with this finding, our results demonstrated a coordinated
migration of DPSCs and HUVECs in PuraMatrix during the
first 48 h until the HUVECs became organized in a capillary
network. Significantly larger and more three-dimensionally
organized vessel-like structures were observed within the
cocultures, in contrast to the tubular structures that were
observed in the HUVEC monocultures supplied with DPSC-
conditioned medium or VEGF. These finding confirmed that
DPSCs facilitated vessel formation via cell migration and
the corresponding scaffold disruption in addition to secret-
ing angiogenic factors. Furthermore, DPSCs may have a
regulatory function in vascular morphogenesis by changing
the extracellular microenvironment via matrix deposition
and metalloproteinase-mediated ECM remodeling, particu-
larly at the later stages.32,33
Interestingly, vessel structure formation was observed after
24 h of encapsulation when the cocultures were injected into
root canals of root segments. This observation may be due to
the hypoxic environment within the root canals, which can be
further explained based on prior studies demonstrating that
hypoxia-derived elements increase VEGF transcription and
subsequent vascular morphogenesis.34
Following in vivo transplantation, a significantly higher
number of vascular lumens was observed in the cocultured
groups compared with the DPSC-alone control group. Im-
munohistochemical labeling of human CD31 indicated that
the majority of the perfused vessels in the cocultured groups
were positively stained for CD31, suggesting that the HUVEC
prevascular structures that had formed in vitro had integrated
with the host vasculature. Furthermore, increased vasculature
was observed at the borders of the transplant and mouse tis-
sue, suggesting that the transplanted cells exerted a paracrine
effect on the host tissues.
The levels of ALP protein and mineralization were
higher in the coculture groups than in the monocultures
in vitro. The current results also indicate that coculturing
leads to increased mineralization and ECM formation
FIG. 10. Neovascularization within the regenerated pulp-
like tissue. (A–C) Immunohistochemical staining of human-
specific CD31 in DPSC:HUVEC 3:1 in PuraMatrix. The
CD31 + vascular lumens located near the host tissues were
perfused (A, C). The majority of the vascular lumens near
the periphery of the transplant (distant from the host tissues)
were not perfused (A, B). Black arrow: border between
the host tissues and transplant, Red arrows: CD31 + per-
fused vessels, Green arrows: CD31 + nonperfused vessels.
Magnifications–(A) 10 · , (B) 50 · , (C) 50 · . (D) Quanti-
fication of the number of perfused vessels within the re-
generated pulp-like tissues of the different transplantation
groups (*p < 0.05).
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within the pulp-like tissue that regenerated in vivo. Fur-
thermore, more vascular lumens were observed near the
mineralizing sites within the regenerated pulp-like tissue
than elsewhere. This finding indicated that the HUVECs
had an inducing effect on mineralization by the DPSCs.
Previous reports have demonstrated that in addition to
a paracrine effect, direct cell–cell contact of HUVECs
with osteoblasts stimulates ALP activity.35–37 Further-
more, HUVECs were shown to secrete BMP-2, which is a
mineralization/bone inducing factor.38 These data explain
the mineralization-promoting effects of HUVECs on
DPSCs.
The period of in vivo transplantation used in this study
was 4 weeks unlike some other studies that chose longer
periods.20 One of the main objectives of this study was to
examine the anastamosis of in vitro formed prevascular
structures of HUVECs with the host vasculature upon
transplantation compared to the DPSC-alone group. This
aspect requires to be examined at relatively early time points
that is, prior to achieve vascular homeostasis within the
regenerated tissue.28 Furthermore, there are previous studies
that used transplantation periods of 2–4 weeks and showed
pulp-like tissue regeneration in similar models.17,39 There-
fore, 4 weeks was identified as the appropriate transplanta-
tion period to achieve the objectives of this study. Although
HUVECs are a readily available source and were used in
this study, HUVECs might not be an option in the clinical
setting due to immune incompatibility. Potential alternatives
include microvascular ECs and endothelial progenitor
cells,40 which have already been investigated in vasculo-
genic studies.
In vivo transplantation of PuraMatrix/cell constructs in
root fragments resulted in the partial regeneration of pulp-
like tissue within the root canals. The pulp-like tissue re-
generated only up to the middle (5mm) to lower third
(3.3mm) of the root canals. Because the coronal openings of
the root fragments were sealed with MTA prior to trans-
plantation, only the apical regions could attain nutrients and
a vascular supply. This result suggested that although pre-
vascularization can enhance vascularization within a cell
construct, this strategy does not allow for the regeneration of
full-length pulps when only the apical region is available for
vascular connection. However, in the root segments in
which the apical opening was larger than average, ingrow-
ing host tissue appeared to push the PuraMatrix/cell trans-
plant toward the coronal end. This result implies the
importance of the size of the apical opening for pulp re-
generation.
Taken together, the foregoing suggests the need to define
a critical defect size and a critical apical opening size for
pulp regeneration. This knowledge would allow for stan-
dardization in studies of regenerative therapy and a pre-
dictable outcome. For example, prevascularized PuraMatrix/
DPSC constructs can be successfully used to regenerate
pulp of up to 5mm in length and can be applied for pulp
regeneration in teeth with an open apex. In cases in which
full-length pulp regeneration is required in a tooth with a
closed root apex, we propose a multiple transplantation
approach, in which 3- to 4-mm segments of pulp are re-
generated at once and multiple transplantations are performed
at intervals to allow vascularization of the transplanted
tissues.
Conclusion
In summary, this study described the novel approach of
utilizing prevascularized PuraMatrix constructs of DPSCs
for pulp regeneration. The results demonstrated that DPSCs
mediated the angiogenic process in vitro, largely via the
expression of the angiogenic factor VEGF. The results also
suggested that EC behavior could be regulated by additional
factors, such as the composition, and remodeling of the
scaffold, all of which are in turn affected by the presence of
DPSCs. Therefore, our results provide insight into the
complex intercellular cross-talk between HUVECs and
DPSCs in relation to angiogenesis and pulp regeneration.
The results of the present study, together with those of recent
in vivo studies of pulp regeneration17 and cardiac regenera-
tion,10,11 suggest that a peptide nanofibrous environment
may be uniquely appropriate as a tissue engineering scaffold
for the regeneration of vascular tissues. Our findings dem-
onstrate the significance of creating a microenvironment that
supports cellular cross-talk and cell migration, which con-
tribute to the creation of an optimal environment for dental
pulp regeneration.
Acknowledgments
This study was supported by a Small Project Funding grant
(project code: 201007176063) from the University of Hong
Kong and a General Research Fund (GRF) grant (project
code: HKU784912M) from the Research Grants Council,
Hong Kong SAR. The funding sources had no role in the
study design, the performance of the study, the analysis and
interpretation of the data, the writing of the report, and the
decision to submit the article for publication. The authors
would like to thank Edith HY Tong and Raymond Tong for
their excellent technical support.
Disclosure Statement
No competing financial interests exist.
References
1. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A.
Vascularization in tissue engineering. Trends Biotechnol
26, 434, 2008.
2. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and
other diseases. Nature 407, 249, 2000.
3. Muschler, G.F., Nakamoto, C., and Griffith, L.G. En-
gineering principles of clinical cell-based tissue engineer-
ing. J Bone Joint Surg Am 86-A, 1541, 2004.
4. Dissanayaka, W.L., Zhan, X., Zhang, C., Hargreaves, K.M.,
Jin, L., and Tong, E.H. Coculture of dental pulp stem cells
with endothelial cells enhances osteo-/odontogenic and
angiogenic potential in vitro. J Endod 38, 454, 2012.
5. Rouwkema, J., de Boer, J., and Van Blitterswijk, C.A.
Endothelial cells assemble into a 3-dimensional prevascular
network in a bone tissue engineering construct. Tissue Eng
12, 2685, 2006.
6. Kelm, J.M., Djonov, V., Ittner, L.M., Fluri, D., Born, W.,
Hoerstrup, S.P., and Fussenegger, M. Design of custom-
shaped vascularized tissues using microtissue spheroids as
minimal building units. Tissue Eng 12, 2151, 2006.
7. Chan, B.P., and Leong, K.W. Scaffolding in tissue engi-
neering: general approaches and tissue-specific consider-
ations. Eur Spine J 17 Suppl 4, 467, 2008.
DPSCs AND ECs IN PEPTIDE HYDROGEL ON PULP REGENERATION 561
8. Davis, M.E., Hsieh, P.C., Takahashi, T., Song, Q., Zhang,
S., Kamm, R.D., Grodzinsky, A.J., Anversa, P., and Lee,
R.T. Local myocardial insulin-like growth factor 1 (IGF-1)
delivery with biotinylated peptide nanofibers improves cell
therapy for myocardial infarction. Proc Natl Acad Sci U S A
103, 8155, 2006.
9. Segers, V.F., Tokunou, T., Higgins, L.J., MacGillivray,
C., Gannon, J., and Lee, R.T. Local delivery of protease-
resistant stromal cell derived factor-1 for stem cell re-
cruitment after myocardial infarction. Circulation 116,
1683, 2007.
10. Davis, M.E., Motion, J.P., Narmoneva, D.A., Takahashi, T.,
Hakuno, D., Kamm, R.D., Zhang, S., and Lee, R.T. In-
jectable self-assembling peptide nanofibers create in-
tramyocardial microenvironments for endothelial cells.
Circulation 111, 442, 2005.
11. Hsieh, P.C., Davis, M.E., Gannon, J., MacGillivray, C., and
Lee, R.T. Controlled delivery of PDGF-BB for myocardial
protection using injectable self-assembling peptide nanofi-
bers. J Clin Invest 116, 237, 2006.
12. Semino, C.E., Kasahara, J., Hayashi, Y., and Zhang, S.
Entrapment of migrating hippocampal neural cells in three-
dimensional peptide nanofiber scaffold. Tissue Eng 10,
643, 2004.
13. Thonhoff, J.R., Lou, D.I., Jordan, P.M., Zhao, X., and Wu,
P. Compatibility of human fetal neural stem cells with
hydrogel biomaterials in vitro. Brain Res 1187, 42, 2008.
14. Wang, S., Nagrath, D., Chen, P.C., Berthiaume, F., and
Yarmush, M.L. Three-dimensional primary hepatocyte
culture in synthetic self-assembling peptide hydrogel. Tissue
Eng Part A 14, 227, 2008.
15. Misawa, H., Kobayashi, N., Soto-Gutierrez, A., Chen, Y.,
Yoshida, A., Rivas-Carrillo, J.D., Navarro-Alvarez, N.,
Tanaka, K., Miki, A., Takei, J., Ueda, T., Tanaka, M.,
Endo, H., Tanaka, N., and Ozaki, T. PuraMatrix facilitates
bone regeneration in bone defects of calvaria in mice. Cell
Transplant 15, 903, 2006.
16. Cavalcanti, B.N., Zeitlin, B.D., and Nor, J.E. A hydrogel
scaffold that maintains viability and supports differen-
tiation of dental pulp stem cells. Dent Mater 29, 97,
2013.
17. Rosa, V., Zhang, Z., Grande, R.H., and Nor, J.E. Dental
pulp tissue engineering in full-length human root canals. J
Dent Res 92, 970, 2013.
18. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and
Shi, S. Postnatal human dental pulp stem cells (DPSCs)
in vitro and in vivo. Proc Natl Acad Sci U S A 97, 13625,
2000.
19. Dissanayaka, W.L., Zhu, X., Zhang, C., and Jin, L.J.
Characterization of dental pulp stem cells isolated from
canine premolars. J Endod 37, 1074, 2011.
20. Huang, G.T., Yamaza, T., Shea, L.D., Djouad, F., Kuhn,
N.Z., Tuan, R.S., and Shi, S. Stem/progenitor cell–mediated
de novo regeneration of dental pulp with newly deposited
continuous layer of dentin in an in vivo model. Tissue Eng
Part A 16, 605, 2010.
21. Coimbra, P., Alves, P., Valente, T.A., Santos, R., Correia,
I.J., and Ferreira, P. Sodium hyaluronate/chitosan poly-
electrolyte complex scaffolds for dental pulp regeneration:
synthesis and characterization. Int J Biol Macromol 49,
573, 2011.
22. Buurma, B., Gu, K., and Rutherford, R.B. Transplantation
of human pulpal and gingival fibroblasts attached to syn-
thetic scaffolds. Eur J Oral Sci 107, 282, 1999.
23. Shi, S., and Gronthos, S. Perivascular niche of postnatal
mesenchymal stem cells in human bone marrow and dental
pulp. J Bone Miner Res 18, 696, 2003.
24. d’Aquino, R., Graziano, A., Sampaolesi, M., Laino, G.,
Pirozzi, G., De Rosa, A., and Papaccio, G. Human
postnatal dental pulp cells co-differentiate into osteo-
blasts and endotheliocytes: a pivotal synergy leading to
adult bone tissue formation. Cell death Differ 14, 1162,
2007.
25. Vogel, V., and Baneyx, G. The tissue engineering puzzle:
a molecular perspective. Annu Rev Biomed Eng 5, 441,
2003.
26. Narmoneva, D.A., Oni, O., Sieminski, A.L., Zhang, S.,
Gertler, J.P., Kamm, R.D., and Lee, R.T. Self-assembling
short oligopeptides and the promotion of angiogenesis.
Biomaterials 26, 4837, 2005.
27. Sieminski, A.L., Semino, C.E., Gong, H., and Kamm, R.D.
Primary sequence of ionic self-assembling peptide gels
affects endothelial cell adhesion and capillary morpho-
genesis. J Biomed Mater Res A 87, 494, 2008.
28. Mullane, E.M., Dong, Z., Sedgley, C.M., Hu, J.C., Botero,
T.M., Holland, G.R., and No¨r, J.E. Effects of VEGF and
FGF2 on the revascularization of severed human dental
pulps. J Dent Res 87, 1144, 2008.
29. No¨r, J.E., Christensen, J., Mooney, D.J., and Polverini, P.J.
Vascular endothelial growth factor (VEGF)-mediated an-
giogenesis is associated with enhanced endothelial cell
survival and induction of Bcl-2 expression. Am J Pathol
154, 375, 1999.
30. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S.,
Wiegand, S.J., and Holash, J. Vascular-specific growth
factors and blood vessel formation. Nature 407, 242,
2000.
31. Hurley, J.R., Balaji, S., and Narmoneva, D.A. Complex
temporal regulation of capillary morphogenesis by fibro-
blasts. Am J Physiol Cell Physiol 299, C444, 2010.
32. Burbridge, M.F., Coge, F., Galizzi, J.P., Boutin, J.A., West,
D.C., and Tucker, G.C. The role of the matrix metallo-
proteinases during in vitro vessel formation. Angiogenesis
5, 215, 2002.
33. Spinale, F.G. Myocardial matrix remodeling and the matrix
metalloproteinases: influence on cardiac form and function.
Physiol Rev 87, 1285, 2007.
34. Rivron, N.C., Liu, J.J., Rouwkema, J., de Boer, J., and van
Blitterswijk, C.A. Engineering vascularised tissues in vitro.
Eur Cell Mater 15, 27, 2008.
35. Villars, F., Bordenave, L., Bareille, R., and Amedee, J.
Effect of human endothelial cells on human bone marrow
stromal cell phenotype: role of VEGF? J Cell Biochem 79,
672, 2000.
36. Kaigler, D., Krebsbach, P.H., West, E.R., Horger, K.,
Huang, Y.C., and Mooney, D.J. Endothelial cell modula-
tion of bone marrow stromal cell osteogenic potential.
FASEB J 19, 665, 2005.
37. Guillotin, B., Bareille, R., Bourget, C., Bordenave, L., and
Amedee, J. Interaction between human umbilical vein en-
dothelial cells and human osteoprogenitors triggers pleio-
tropic effect that may support osteoblastic function. Bone
42, 1080, 2008.
38. Wang, J., Ye, Y., Tian, H., Yang, S., Jin, X., Tong, W., and
Zhang, Y. In vitro osteogenesis of human adipose-derived
stem cells by coculture with human umbilical vein endo-
thelial cells. Biochem Biophys Res Commun 412, 143,
2011.
562 DISSANAYAKA ET AL.
39. Cordeiro, M.M., Dong, Z., Kaneko, T., Zhang, Z., Miya-
zawa, M., Shi, S., Smith, A.J., and No¨r, J.E. Dental pulp
tissue engineering with stem cells from exfoliated decidu-
ous teeth. J Endod 34, 962, 2008.
40. Rouwkema, J., Westerweel, P.E., de Boer, J., Verhaar,
M.C., and van Blitterswijk, C.A. The use of endothelial
progenitor cells for prevascularized bone tissue engineer-
ing. Tissue Eng Part A 15, 2015, 2009.
Address correspondence to:
Chengfei Zhang, DDS, PhD
Department of Endodontics
Comprehensive Dental Care
Faculty of Dentistry
The University of Hong Kong
3A15, Prince Philip Dental Hospital
34, Hospital Road
Hong Kong SAR
China
E-mail: zhangcf@hku.hk
Received: March 11, 2014
Accepted: September 4, 2014
Online Publication Date: October 10, 2014
DPSCs AND ECs IN PEPTIDE HYDROGEL ON PULP REGENERATION 563
